Microbot Medical Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MBOT research report →
About the company
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products.
- CEO
- Harel Gadot
- IPO
- 1992
- Employees
- 20
- HQ
- Hingham, MA, US
Price Chart
- Market Cap
- $87.04M
- P/E
- -6.91
- P/S
- 828.95
- P/B
- 1.73
- EV/EBITDA
- -5.95
- Div Yield
- 0.00%
- Gross Margin
- -9.52%
- Op Margin
- -15278.10%
- Net Margin
- -13535.24%
- ROE
- -21.84%
- ROIC
- -21.39%
- Revenue
- $0 · 0.00%
- Net Income
- $-13,142,000 · -14.85%
- EPS
- $-0.29 · 60.27%
- Op Income
- $-14,743,000
- FCF YoY
- -48.06%
- 52W High
- $4.67
- 52W Low
- $1.60
- 50D MA
- $1.94
- 200D MA
- $2.27
- Beta
- 1.03
- Avg Volume
- 1.51M
Get TickerSpark's AI analysis on MBOT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 1, 26 | Stockburger Aileen Ptucha | other | 10,000 |
| Apr 1, 26 | Madden Martin J. | other | 10,000 |
| Apr 1, 26 | Wenderow Tal Baruch | other | 10,000 |
| Apr 1, 26 | Wilson David James | other | 10,000 |
| Apr 1, 26 | Burell Scott R | other | 10,000 |
| Apr 1, 26 | Laxminarain Prattipati | other | 10,000 |
| Feb 18, 26 | Gadot Harel | other | 480,000 |
| Feb 18, 26 | Diaz-Cartelle Juan | other | 105,000 |
| Feb 18, 26 | Sharon Simon | other | 105,000 |
| Feb 18, 26 | Vaknin Rachel | other | 105,000 |
Our MBOT coverage
Recent articles, reports, and earnings notes.
No research on MBOT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MBOT report →Similar companies
Peers in the same neighborhood.